Monte Rosa Therapeutics, Inc. (GLUE)
17.17
+0.72
(+4.38%)
USD |
NASDAQ |
Apr 01, 16:00
17.15
-0.02
(-0.12%)
Pre-Market: 20:00
Monte Rosa Therapeutics EPS Diluted (Quarterly) : -0.7039 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Agenus, Inc. | -0.301 |
| Amicus Therapeutics, Inc. | 0.0054 |
| CorMedix, Inc. | 0.1493 |
| BioRestorative Therapies, Inc. | -0.3614 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.14M |
| Revenue (Quarterly) | 2.781M |
| Total Expenses (Quarterly) | 48.92M |
| Enterprise Value | 1.036B |
| Gross Profit Margin (Quarterly) | 24.92% |
| Profit Margin (Quarterly) | -1.66K% |
| Earnings Yield | -3.45% |
| Normalized Earnings Yield | -3.447 |